.
New Delhi, April 26 (MondayMirror.com) The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Source: IANS
For years, Aishwarya Rai Bachchan has remained one of the most iconic Indian celebrities to…
50-Balls Cricket Association of Chandigarh’s Under-15 and Under-19 Boys Teams Leave for Odisha for…
For decades, online casino players have had to trust the "black box" of Random Number…
RJ Mahvash has confirmed that she will be a part of the upcoming second season…
Alia Bhatt has once again become one of the most talked-about Indian celebrities at the…
Mohali: ISAAC Luxe, a leading name in advanced aesthetic and wellness solutions has announced the…